Emerging Infectious Diseases (Nov 2021)

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis

  • Nico A.F. Janssen,
  • Rémy Nyga,
  • Lore Vanderbeke,
  • Cato Jacobs,
  • Mehmet Ergün,
  • Jochem B. Buil,
  • Karin van Dijk,
  • Josje Altenburg,
  • Catherine S.C. Bouman,
  • Hans I. van der Spoel,
  • Bart J.A. Rijnders,
  • Albert Dunbar,
  • Jeroen A. Schouten,
  • Katrien Lagrou,
  • Marc Bourgeois,
  • Marijke Reynders,
  • Niels van Regenmortel,
  • Lynn Rutsaert,
  • Piet Lormans,
  • Simon Feys,
  • Yves Debavaye,
  • Fabienne Tamion,
  • Damien Costa,
  • Julien Maizel,
  • Hervé Dupont,
  • Taieb Chouaki,
  • Saad Nseir,
  • Boualem Sendid,
  • Roger J.M. Brüggemann,
  • Frank L. van de Veerdonk,
  • Joost Wauters,
  • Paul E. Verweij

DOI
https://doi.org/10.3201/eid2711.211174
Journal volume & issue
Vol. 27, no. 11
pp. 2892 – 2898

Abstract

Read online

We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA). We found 10%–15% CAPA incidence among 823 patients in 2 cohorts. Several factors were independently associated with CAPA in 1 cohort and mortality rates were 43%–52%.

Keywords